GSK-1292263 ≥98% (by HPLC)

Synonyms: 3-isopropyl-5-(4-(((6-(4-(methylsulfonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole3-isopropyl-5-(4-(((6-(4-(methylsulphonyl)phenyl)pyridin-3-yl)oxy)methyl)piperidin-1-yl)-1,2,4-oxadiazole

B1556-5 B1556-25
76270-370EA 758.88 USD
76270-370 76270-368
GSK-1292263 ≥98% (by HPLC)
GSK-1292263

GSK-1292263 is a novel GPR119 receptor agonist and is used for the treatment of type 2 diabetes. GSK1292263 improves glucose regulation in animal models of diabetes, but has no effect on plasma glucose in type 2 diabetics.

Formula: C₂₃H₂₈N₄O₄S
MW: 456,56 g/mol
MDL Number: MFCD18385004
CAS Number: 1032823-75-8
https://us.vwr.com/stibo/web/std.lang.all/17/36/24101736.jpg

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR